The deal covers global rights to three brands – Zinnat (cefuroxime axetil), Zinacef (cefuroxime ... but in the meantime GSK has agreed to continue to supply the drug for the next four years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback